Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown
Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown Sheryar Siddiq Sun, November 30, 2025 at 2:08 AM GMT+8 1 min read In this article: CRSP +0.32% CRISPR Therap...